Origami Therapeutics, Inc.Oral drugs to halt neurodegeneration

Origami Therapeutics, Inc.

Origami Therapeutics is developing next-generation protein degraders and correctors to treat neurodegenerative diseases. Our technology selectively targets and degrades disease-related proteins, leaving normal proteins intact.

Product Highlights

• Feature 1: Protein degradation technology to efficiently and selectively target and degrade harmful proteins.
• Feature 2: Small molecule therapies for broad distribution in the body and ease of manufacture.
• Feature 3: Focus on neurodegenerative diseases like Alzheimer's, Huntington's, and Parkinson's Diseases.

Use Cases

• Use case 1: Treatment of neurodegenerative diseases by targeting and removing harmful proteins.
• Use case 2: Development of new therapies for neurodegenerative diseases like Alzheimer's and Huntington's.
• Use case 3: Offering novel treatment options for patients suffering from neurodegenerative diseases.

Target Audience

Origami Therapeutics focuses on developing new treatments for neurodegenerative diseases and providing them to individuals affected by these conditions.